» Articles » PMID: 39408565

Update on the Role of β2AR and TRPV1 in Respiratory Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 16
PMID 39408565
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory diseases (RDs) constitute a common public health problem both in industrialized and developing countries. The comprehension of the pathophysiological mechanisms underlying these conditions and the development of new therapeutic strategies are critical for improving the quality of life of affected patients. β2-adrenergic receptor (β2AR) and transient receptor potential vanilloid 1 (TRPV1) are both involved in physiological responses in the airways. β2AR is implicated in bronchodilation, mucociliary clearance, and anti-inflammatory effects, while TRPV1 is involved in the mediation of pain and cough reflexes. In RDs, such as respiratory infections, asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, the concentration and expression of these receptors can be altered, leading to significant consequences. In this review, we provided an update on the literature about the role of β2AR and TRPV1 in these conditions. We reported how the diminished or defective expression of β2AR during viral infections or prolonged therapy with β2-agonists can increase the severity of these pathologies and impact the prognosis. Conversely, the role of TRPV1 was pivotal in neuroinflammation, and its modulation could lead to innovative treatment strategies in specific patients. We indicate future perspectives and potential personalized treatments in RDs through a comprehensive analysis of the roles of these receptors in the physiological and pathological mechanisms of these pathologies.

Citing Articles

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants.

Calomfirescu-Avramescu A, Toma A, Mehedintu C, Nastase L, Dima V Vaccines (Basel). 2025; 13(2).

PMID: 40006718 PMC: 11861343. DOI: 10.3390/vaccines13020171.


The Association Between Respiratory Viruses and Asthma Exacerbation in Children Visiting Pediatric Emergency Department: A Retrospective Cohort Study.

Lee W, Song J, Shin J, Choi S, Han M, Lee K J Clin Med. 2025; 14(4).

PMID: 40004841 PMC: 11856561. DOI: 10.3390/jcm14041311.

References
1.
Manti S, Staiano A, Orfeo L, Midulla F, Marseglia G, Ghizzi C . UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023; 49(1):19. PMC: 9912214. DOI: 10.1186/s13052-022-01392-6. View

2.
. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023; 59:101936. PMC: 7614570. DOI: 10.1016/j.eclinm.2023.101936. View

3.
Brewington J, Backstrom J, Feldman A, Kramer E, Moncivaiz J, Ostmann A . Chronic β2AR stimulation limits CFTR activation in human airway epithelia. JCI Insight. 2018; 3(4). PMC: 5916247. DOI: 10.1172/jci.insight.93029. View

4.
Hamutcu R, Francis J, Karakoc F, Bush A . Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol. 2002; 34(5):331-5. DOI: 10.1002/ppul.10174. View

5.
Omar S, Clarke R, Abdullah H, Brady C, Corry J, Winter H . Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells. PLoS One. 2017; 12(2):e0171681. PMC: 5302416. DOI: 10.1371/journal.pone.0171681. View